Real-world Data on Intermediate-risk Differentiated Thyroid Cancer Biochemical Response to 3700 or 5550 MBq of [<sup>131</sup>I]Sodium Iodide
Intermediate risk thyroid-cancer patients presented similar therapeutic responses to the doses of 3700 MBq and 5550 MBq [<sup>131</sup>I]Sodium Iodide.
Authors
- Daniel Nascimento Machado (ORCID: https://orcid.org/0000-0003-1831-7092)
- S. Locatelli
- Priscilla Brunelli Pujatti (ORCID: https://orcid.org/0000-0002-1165-8049)
- Lídia Freitas Fontes (ORCID: https://orcid.org/0000-0002-3860-2408)
- Daniel Bulzico (ORCID: https://orcid.org/0000-0003-1270-7241)
- Rossana Corbo Ramalho de Mello
Institutions
- Hospital do Câncer III (BR)
- Instituto Nacional de Câncer - INCA (BR)
Publication Details
- Journal
- Current Radiopharmaceuticals
- Published
- 2025-05-07
- DOI
- https://doi.org/10.2174/0118744710374569250415095218
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00